Abstract
Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response.
Boulos Haraoui, Louise Cameron, Michèle Ouellet and Barbara White
The Journal of Rheumatology January 2006, 33 (1) 31-36;
Boulos Haraoui
Louise Cameron
Michèle Ouellet
In this issue
The Journal of Rheumatology
Vol. 33, Issue 1
1 Jan 2006
Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response.
Boulos Haraoui, Louise Cameron, Michèle Ouellet, Barbara White
The Journal of Rheumatology Jan 2006, 33 (1) 31-36;